RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Skin Cancer

A collection of news and information related to Skin Cancer published by this site and its partners.

Top Skin Cancer Articles

Displaying items 85-96
  • Florida Hospital surgeon issues call to urgency on skin cancer

    Florida Hospital surgeon issues call to urgency on skin cancer
    There are environmental factors to consider, Rhonda Harmon noted, but also two simple explanations: people love spending time at the beach, and in our culture, some equate beauty with a really great tan. “Most people, I think it’s fair to...
  • Fragile ozone layer shows first sign of recovery: U.N.

    GENEVA (Reuters) - The ozone layer that shields life from cancer-causing solar rays is showing its first sign of recovery after years of dangerous depletion, a U.N. study said on Wednesday, in a rare piece of good news on the environment. Experts said it...
  • Healing waters? It's what the beach life does for us

     Healing waters? It's what the beach life does for us
    Ahhh, the beach. The baking sun, soft sand, cresting waves and sea breeze on your face. There's nothing quite like spending time at South Florida's beaches. Why do we feel so good there? And are the benefits from the beach physical or psychological?...
  • FDA approves new drug for melanoma, part of UVA clinical trial

    FDA approves new drug for melanoma, part of UVA clinical trial
    The FDA approved the first in a new class of drugs for better melanoma care, and with applications to other cancers. Read the story here in Modern Healthcare: http://www.modernhealthcare.com/article/20140905/INFO/309059978&utm_source=AltURL&utm_...
  • Bristol-Myers sues Merck over U.S. immunotherapy patent

    (Reuters) - Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages. Immunotherapy is a mechanism that uses the body's own immune system to...
  • Bristol-Myers demanda a Merck por patente de inmunoterapia en EEUU

    (Reuters) - La farmacéutica Bristol-Myers Squibb Co presentó una demanda el jueves contra Merck & Co Inc por la supuesta violación de su patente de inmunoterapia. La compañía está buscando una compensación por daños no especificada. La inmunoterapia es...
  • Melanoma drug described as breakthrough gets FDA nod

    The Food and Drug Administration on Thursday gave its speedy approval to a treatment for melanoma that was found to shrink tumors by more than 30% in more than a third of patients with advanced cases of the deadly skin cancer. The FDA designated the...
  • U.S. approves Merck immune-stimulating drug for melanoma

    (Reuters) - U.S. regulators on Thursday approved the use of Merck & Co Inc's immuno-oncology drug Keytruda, also known as pembrolizumab, as a treatment for patients with advanced melanoma who are no longer responding to other therapies. The decision...
  • Melanoma risk is higher for flight crews that work at 40,000 feet

    Melanoma risk is higher for flight crews that work at 40,000 feet
    Attention pilots and flight attendants: For your safety, please fasten your seat belts, note the location of the aircraft’s emergency exits -- and be sure to apply plenty of sunscreen to reduce your risk of melanoma. When it comes to the risks...
  • Airline crews may be more likely to get skin cancer

    NEW YORK (Reuters Health) – Pilots and flight attendants may be at an increased risk of developing the most deadly form of skin cancer, suggests a new analysis. While the study cannot pinpoint why flight crews are at higher risk, the researchers...
  • Free screening for skin cancer offered

    Free screening for skin cancer offered
    Ever have one of those little places on your arm that could be a mole or a freckle or a bump? And has it changed color or size in the past year? Central Florida Health Alliance has partnered with the Moffitt Cancer Center and local dermatologists to...
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...